Voluntary versus mechanically-induced deep inspiration breath-hold for left breast cancer: A randomized controlled trial.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
06 2023
Historique:
received: 15 10 2022
revised: 14 02 2023
accepted: 28 02 2023
medline: 5 6 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

Deep inspiration breath-hold (DIBH) protects critical organs-at-risk (OARs) for adjuvant breast radiotherapy. Guidance systems e.g. surface guided radiation therapy (SGRT) improve the positional breast reproducibility and stability during DIBH. In parallel, OARs sparing with DIBH is enhanced through different techniques e.g. prone position, continuous positive airway pressure (CPAP). By inducing repeated DIBH with the same level of positive pressure, mechanically-assisted and non-invasive ventilation (MANIV) could potentially combine these DIBH optimizations. We conducted a randomized, open-label, multicenter and single-institution non-inferiority trial. Sixty-six patients eligible for adjuvant left whole-breast radiotherapy in supine position were equally assigned between mechanically-induced DIBH (MANIV-DIBH) and voluntary DIBH guided by SGRT (sDIBH). The co-primary endpoints were positional breast stability and reproducibility with a non-inferiority margin of 1 mm. Secondary endpoints were tolerance assessed daily via validated scales, treatment time, dose to OARs and their inter-fraction positional reproducibility. Differences between both arms for positional breast reproducibility and stability occurred at a sub-millimetric level (p < 0.001 for non-inferiority). The left anterior descending artery near-max dose (14,6 ± 12,0 Gy vs. 7,7 ± 7,1 Gy, p = 0,018) and mean dose (5,0 ± 3,5 Gy vs. 3,0 ± 2,0 Gy, p = 0,009) were improved with MANIV-DIBH. The same applied for the V Mechanical ventilation provides the same target irradiation accuracy as with SGRT while better protecting and repositioning OARs.

Sections du résumé

BACKGROUND AND PURPOSE
Deep inspiration breath-hold (DIBH) protects critical organs-at-risk (OARs) for adjuvant breast radiotherapy. Guidance systems e.g. surface guided radiation therapy (SGRT) improve the positional breast reproducibility and stability during DIBH. In parallel, OARs sparing with DIBH is enhanced through different techniques e.g. prone position, continuous positive airway pressure (CPAP). By inducing repeated DIBH with the same level of positive pressure, mechanically-assisted and non-invasive ventilation (MANIV) could potentially combine these DIBH optimizations.
MATERIALS AND METHODS
We conducted a randomized, open-label, multicenter and single-institution non-inferiority trial. Sixty-six patients eligible for adjuvant left whole-breast radiotherapy in supine position were equally assigned between mechanically-induced DIBH (MANIV-DIBH) and voluntary DIBH guided by SGRT (sDIBH). The co-primary endpoints were positional breast stability and reproducibility with a non-inferiority margin of 1 mm. Secondary endpoints were tolerance assessed daily via validated scales, treatment time, dose to OARs and their inter-fraction positional reproducibility.
RESULTS
Differences between both arms for positional breast reproducibility and stability occurred at a sub-millimetric level (p < 0.001 for non-inferiority). The left anterior descending artery near-max dose (14,6 ± 12,0 Gy vs. 7,7 ± 7,1 Gy, p = 0,018) and mean dose (5,0 ± 3,5 Gy vs. 3,0 ± 2,0 Gy, p = 0,009) were improved with MANIV-DIBH. The same applied for the V
CONCLUSION
Mechanical ventilation provides the same target irradiation accuracy as with SGRT while better protecting and repositioning OARs.

Identifiants

pubmed: 36898583
pii: S0167-8140(23)00136-6
doi: 10.1016/j.radonc.2023.109598
pii:
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109598

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Loïc Vander Veken (L)

UCLouvain, Institut de Recherche Experimentale et Clinique (IREC), Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), 1200 Brussels, Belgium; Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium. Electronic address: loic.vanderveken@uclouvain.be.

Geneviève Van Ooteghem (G)

UCLouvain, Institut de Recherche Experimentale et Clinique (IREC), Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), 1200 Brussels, Belgium; Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Ariane Razavi (A)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Sergio Da Rita Quaresma (S)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Eleonore Longton (E)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Carine Kirkove (C)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Benjamin Ledoux (B)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Ad Vandermeulen (A)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Christel Abdel Massih (C)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Pascale Henderickx (P)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Mortimer Gabriels (M)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Céline Delvaux (C)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Faycal Salah (F)

Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Aude Vaandering (A)

UCLouvain, Institut de Recherche Experimentale et Clinique (IREC), Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), 1200 Brussels, Belgium; Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Xavier Geets (X)

UCLouvain, Institut de Recherche Experimentale et Clinique (IREC), Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), 1200 Brussels, Belgium; Radiation Oncology Department, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH